Published in Schizophr Res on February 23, 2012
MR connectomics: a conceptual framework for studying the developing brain. Front Syst Neurosci (2012) 1.16
The promise of biological markers for treatment response in first-episode psychosis: a systematic review. Schizophr Bull (2015) 1.03
Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders. Schizophr Bull (2013) 0.83
Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers. Transl Psychiatry (2016) 0.81
No evidence of exogenous origin for the abnormal glutathione redox state in schizophrenia. Schizophr Res (2013) 0.81
Predictors of outcome in early-onset psychosis: a systematic review. NPJ Schizophr (2015) 0.78
Peripheral antioxidant markers are associated with total hippocampal and CA3/dentate gyrus volume in MDD and healthy controls-preliminary findings. Psychiatry Res (2014) 0.77
Gender effects on brain changes in early-onset psychosis. Eur Child Adolesc Psychiatry (2015) 0.76
Fusing Sensor Paradigms to Acquire Chemical Information: An Integrative Role for Smart Biopolymeric Hydrogels. Adv Healthc Mater (2016) 0.76
Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk. Int J Mol Sci (2017) 0.75
Erythrocyte glutathione levels as long-term predictor of transition to psychosis. Transl Psychiatry (2017) 0.75
Perinatal complications, lipid peroxidation, and mental health problems in a large community pediatric sample. Eur Child Adolesc Psychiatry (2016) 0.75
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30
Cognition in schizophrenia: summary Nice Consultation Meeting 2012. Eur Neuropsychopharmacol (2013) 3.99
Predictors of suicide attempt in early-onset, first-episode psychoses: a longitudinal 24-month follow-up study. J Clin Psychiatry (2012) 3.45
Depression in bipolar disorder versus major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Bipolar Disord (2012) 2.47
Morphometric assessment of the heteromodal association cortex in schizophrenia. Am J Psychiatry (2004) 2.27
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21
The continuum of psychotic symptoms in the general population: a cross-national study. Schizophr Bull (2010) 1.94
Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study. Schizophr Res (2006) 1.88
Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry (2013) 1.75
ROAMER: roadmap for mental health research in Europe. Int J Methods Psychiatr Res (2014) 1.67
Spatio-temporal nonrigid registration for ultrasound cardiac motion estimation. IEEE Trans Med Imaging (2005) 1.66
Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J Clin Psychiatry (2009) 1.61
Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: a corollary from the CLAMORS study. Schizophr Res (2007) 1.47
Comorbidity and phenomenology of bipolar disorder in children with ADHD. J Atten Disord (2012) 1.46
Waking-like brain function in embryos. Curr Biol (2012) 1.41
Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage (2003) 1.36
Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. Eur Neuropsychopharmacol (2009) 1.36
The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry (2002) 1.34
Exploring brief measures of nicotine dependence for epidemiological surveys. Addict Behav (2003) 1.34
Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophr Bull (2005) 1.34
Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropsychopharmacol (2011) 1.31
Assessment of the increase in variability when combining volumetric data from different scanners. Hum Brain Mapp (2009) 1.30
Tracking of regions-of-interest in myocardial contrast echocardiography. Ultrasound Med Biol (2004) 1.21
ECNP consensus meeting. Bipolar depression. Nice, March 2007. Eur Neuropsychopharmacol (2008) 1.21
Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur Neuropsychopharmacol (2010) 1.20
18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys (2004) 1.20
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Eur Neuropsychopharmacol (2009) 1.19
Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med (2009) 1.19
Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull (2009) 1.17
The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs. Am J Pathol (2009) 1.17
Association between smoking and alcohol use in the general population: stable and unstable odds ratios across two years in two different countries. Alcohol Alcohol (2007) 1.14
Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients. Neuroimage (2004) 1.13
Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry (2004) 1.12
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics. J Clin Psychiatry (2008) 1.10
Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia. Schizophr Res (2005) 1.09
Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res (2010) 1.09
The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma. Blood (2005) 1.09
Child and adolescent psychiatry: the need for training and development. Rev Psiquiatr Salud Ment (2012) 1.07
Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis: results from the WHO World Health Survey. World Psychiatry (2013) 1.07
Longitudinal brain changes in early-onset psychosis. Schizophr Bull (2008) 1.06
Treatment nonadherence and neurocognitive impairment in bipolar disorder. J Clin Psychiatry (2009) 1.05
The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem. J Neurochem (2005) 1.05
Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. BMC Psychiatry (2011) 1.03
Gyral and sulcal cortical thinning in adolescents with first episode early-onset psychosis. Biol Psychiatry (2009) 1.03
Constitutive activation of B-Raf in the mouse germ line provides a model for human cardio-facio-cutaneous syndrome. Proc Natl Acad Sci U S A (2011) 1.02
Bipolar disorder in children and adolescents: international perspective on epidemiology and phenomenology. Bipolar Disord (2005) 1.02
Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry (2012) 1.02
Does diagnostic classification of early-onset psychosis change over follow-up? Child Psychiatry Hum Dev (2007) 1.00
Brain changes in children and adolescents with obsessive-compulsive disorder before and after treatment: a voxel-based morphometric MRI study. Psychiatry Res (2009) 0.99
The child and adolescent first-episode psychosis study (CAFEPS): design and baseline results. Schizophr Res (2007) 0.99
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull (2013) 0.98
Regional gray matter volume deficits in adolescents with first-episode psychosis. J Am Acad Child Adolesc Psychiatry (2008) 0.98
The human cerebral cortex flattens during adolescence. J Neurosci (2013) 0.97
Augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence. Neuropsychopharmacology (2007) 0.97
Cortical thickness and voxel-based morphometry in depressed elderly. Eur Neuropsychopharmacol (2010) 0.96
Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). Schizophr Res (2009) 0.95
Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway. Biol Psychiatry (2012) 0.95
Hippocampal volume change in schizophrenia. J Clin Psychiatry (2010) 0.95
Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. Am J Psychiatry (2006) 0.95